The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.

A trial in Italy that's testing Avextra’s cannabis-based medicine for ALS and other neurodegenerative diseases enrolled its ...

Despite the inaccessibility of an "accessible" bathroom stall, columnist Dagmar Munn finds the humor in the situation.

A new dashboard by the ALS Association offers free and open access to real-world data from more than 4,000 people affected by ...

People with ALS in the U.S. spend over $47,000 for medical care in the year after diagnosis, more than 3.5 times the average ...

Columnist Kristin Neva compares how ALS affects various parts of your identity, whether you're a patient or a caregiver.

Researchers have identified new blood and spinal fluid biomarkers that could help track ALS progression and monitor treatment ...

Former Texas A&M football player Chris Larkin will lead the Aggieland Against ALS festival to raise funds for ALS research.

Living with ALS has taken a toll, but columnist Kristin Neva feels like she is doing better now than she has in a long time.

Columnist Dagmar Munn says her ALS diagnosis unexpectedly changed her mental clock. Every second of life became significant, she says.

Researchers developed a cell-free DNA blood test that accurately distinguishes ALS from other neurological diseases and tracks progression.